Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clotrimazole nanogel versus standard clotrimazole for dermatophytosis
IRCT20260502069237N1Phase 3Recruiting
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clotrimazole in dermatophytosis (2 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoints: Lesion extent, Lesion thickness and 1 more. Started Aug 2026; status: recruiting.
02
Drugs
clotrimazole
03
Conditions
dermatophytosis
Beyond the preview
Go deeper on IRCT20260502069237N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260502069237N1.